09:54 AM EST - Adent Capital Corp. : And Khiron Life Sciences Corp. have signed a non-binding letter of intent in relation to a proposed business combination that would result in the takeover of Adent by Khiron. The resulting entity will hold all of the assets and continue the business of Khiron Life Sciences, an integrated medical cannabis company with core operations in Colombia. Adent Capital Corp.
shares V.ANT are trading unchanged at $0.13.
